sentences:  Isavuconazole, a broad-spectrum triazole antifungal drug in Phase III clinical development  has won orphan drug status in the United States.Basilea partnered with pharmaceutical company Astellas Pharma Inc., which holds the U.S. rights to the drug, to conduct two phase 3 clinical trials.The trials demonstrated safety and efficacy in adults with invasive fungal infections.